The Senior Field Clinical Coordinator educates patients on the safe use of BioMarin therapies and collaborates with clinics and account teams to support patient initiation and adherence. They also provide in-person support for self-administration and lead educational initiatives to raise awareness about disease states and treatment options.
The Associate Director serves as the primary finance business partner to Technical Development and Global Quality, providing strategic financial analysis and operational support. They lead annual operating plans, forecasts, and long-range planning while ensuring financial alignment with business priorities and enterprise commitments.
The Senior MSL will cultivate relationships with thought leaders to facilitate scientific exchange and provide strategic insights to internal stakeholders. They will also support clinical trial activities, investigator-initiated research, and provide medical education across various healthcare specialties.
The Senior MSL will cultivate relationships with thought leaders through scientific exchange and provide strategic insights to internal stakeholders. They will also support clinical trial activities, investigator-initiated research, and provide medical education across the product lifecycle.
Maximize sales of commercialized products by driving disease awareness and identifying potential patients within institutional and community settings. Develop and implement strategic business plans to increase market share and maintain relationships with key healthcare providers.
The Sr. Account Manager is responsible for maximizing sales of commercialized products and achieving territory goals across four states. This includes developing business plans, maintaining relationships with healthcare providers, and promoting disease awareness and patient compliance.
Lead the strategic design and execution of early clinical development plans from first-in-human studies through clinical proof of concept. Collaborate with cross-functional teams to integrate translational science and biomarkers into regulatory filings and development decisions.
